Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Assets Average (2021 - 2025)

Roivant Sciences' Assets Average history spans 5 years, with the latest figure at $5.1 billion for Q4 2025.

  • For Q4 2025, Assets Average fell 14.26% year-over-year to $5.1 billion; the TTM value through Dec 2025 reached $5.1 billion, down 14.26%, while the annual FY2025 figure was $5.6 billion, 22.74% down from the prior year.
  • Assets Average reached $5.1 billion in Q4 2025 per ROIV's latest filing, up from $5.0 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $7.3 billion in Q1 2024 to a low of $2.1 billion in Q3 2023.
  • Average Assets Average over 5 years is $4.1 billion, with a median of $3.0 billion recorded in 2021.
  • Peak YoY movement for Assets Average: decreased 25.14% in 2022, then skyrocketed 216.49% in 2024.
  • A 5-year view of Assets Average shows it stood at $3.0 billion in 2021, then fell by 25.14% to $2.2 billion in 2022, then skyrocketed by 112.25% to $4.7 billion in 2023, then rose by 27.94% to $6.0 billion in 2024, then decreased by 14.26% to $5.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Assets Average are $5.1 billion (Q4 2025), $5.0 billion (Q3 2025), and $5.2 billion (Q2 2025).